Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
69.35 EUR | +1.31% | -7.31% | -12.91% |
Mar. 26 | CompuGroup Medical to Initiate EUR16 Million Share Buyback Program | MT |
Mar. 25 | CompuGroup Medical SE & Co. KGaA Announces Chief Executive Officer for the US Changes | CI |
Sales 2023 | 1.19B 1.28B | Sales 2024 * | 1.25B 1.34B | Capitalization | 1.51B 1.63B |
---|---|---|---|---|---|
Net income 2023 | 45M 48.51M | Net income 2024 * | 94M 101M | EV / Sales 2023 | 2.26 x |
Net Debt 2023 | 703M 757M | Net Debt 2024 * | 618M 666M | EV / Sales 2024 * | 1.71 x |
P/E ratio 2023 |
43.1
x | P/E ratio 2024 * |
15.9
x | Employees | - |
Yield 2023 * |
1.94% | Yield 2024 * |
2.08% | Free-Float | 46.87% |
Latest transcript on CompuGroup Medical Societas Europaea
1 day | +1.31% |
Managers | Title | Age | Since |
---|---|---|---|
Frank Gotthardt
CEO | Chief Executive Officer | 72 | 86-12-31 |
Daniel Gotthardt
BRD | Director/Board Member | - | 03-08-21 |
Claudia Thomé
IRC | Investor Relations Contact | 54 | 19-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Gotthardt
BRD | Director/Board Member | - | 03-08-21 |
Director/Board Member | 59 | 20-06-17 | |
Klaus Esser
BRD | Director/Board Member | - | 03-05-25 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.82% | 344B | |
+28.84% | 229B | |
+7.43% | 156B | |
+13.55% | 58.17B | |
+7.37% | 31.59B | |
+8.12% | 31.28B | |
+203.85% | 32.56B | |
+24.65% | 20.13B | |
+7.38% | 16B |
- Stock
- Equities
- Stock CompuGroup Medical SE & Co. KGaA
- Stock CompuGroup Medical Societas Europaea - Xetra